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 17 
ABSTRACT 18 
Wastewater-based epidemiology is increasingly being used as a tool to monitor drug use trends. 19 
To minimize costs, studies have typically monitored a small number of days. However, cycles of 20 
drug use may display weekly and seasonal trends that affect the accuracy of monthly or annual 21 
drug use estimates based on a limited number of samples. This study aimed to rationalize 22 
sampling methods for minimizing the number of samples required while maximizing information 23 
about temporal trends. A range of sampling strategies were examined: i) targeted days (e.g. 24 
weekends), ii) completely random or stratified random sampling, and iii) a number of sampling 25 
strategies informed by known weekly cycles in drug use data. Using a time-series approach, 26 
analysis was performed for four drugs (MDMA, methamphetamine, cocaine, methadone) 27 
collected through a continuous sampling program over 14 months. Results showed, for drugs 28 
with weekly cycles (MDMA, methamphetamine and cocaine in this sample), sampling strategies 29 
which made use of those weekly cycles required fewer samples to obtain similar information as 30 
sampling five days per week and had better accuracy than stratified random sampling techniques. 31 
  32 
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1 Introduction 33 
Over the last decade, wastewater-based epidemiology (WBE) has become increasingly popular 34 
as a method for monitoring trends in illicit substance consumption, as a complement to existing 35 
consumer surveys and examination of health and law enforcement data. One of the key benefits 36 
of WBE is it enables objective data to be collected on illicit drug use in a defined population 37 
without major ethical issues (Hall et al., 2012).  38 
In order to effectively inform policy and interventions to reduce harm from substance use, it 39 
would be ideal to collect information on changes in drug use on an ongoing basis. However, 40 
undertaking longitudinal monitoring programs to assess temporal trends in population drug use 41 
remains challenging since it is resource intensive. Most WBE studies to date have relied on 42 
opportunistic sampling to assess variation in drug use, for example daily samples taken from two 43 
days (weekdays vs. weekends) over a few months or from selected weeks or months per year 44 
(e.g. van Nuijs et al., 2009; Prichard et al., 2012; Zuccato et al., 2011; Khan et al., 2014; Kim et 45 
al., 2015). While it is clear that the uncertainties associated with estimation of drug use levels 46 
decrease with an increase in the number of samples, the cost and amount of time associated with 47 
labor, sampling, sample preparation and instrumental analysis presents a challenge which can 48 
limit the application of WBE for continuous long-term monitoring schemes. As such, it is 49 
important to determine the most efficient manner to structure a monitoring scheme with which to 50 
obtain a clear picture of long term trends, short-term variation (e.g. whether there are changes in 51 
the drug market following large drug seizures or during holiday periods) and weekly cycles in 52 
drug use levels.  53 
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Ort et al. (2014) addressed this question by evaluating a number of sampling scenarios (also 54 
referred to as ‘monitoring scenarios’) for estimating cocaine use in a small catchment (<10,000 55 
inhabitants), identifying that a stratified random (SR) sampling of 56 days per year (14 days per 56 
season; 4 of which fell on weekends; not necessarily consecutively sampled; SR-56) was optimal 57 
for situations where monitoring the average yearly usage is the key aim. If a more detailed 58 
understanding of usage is required beyond changes in yearly average use - for example, to 59 
ascertain changes in monthly average usage, changes in baseline usage or changes in peak usage 60 
throughout a year - then sampling and analysis may need to occur more often than in the SR-56 61 
scenario. Ort et al. (2014) only examined monitoring scenarios for a single target drug, so it is 62 
important to determine the applicability of such schemes to other substances with different 63 
consumption patterns. It also raises the interesting question of how to optimize collection if 64 
information for multiple drugs needs to be obtained via one monitoring scheme. 65 
Given that WBE data often shows that illicit drug use is subject to strong weekly and seasonal 66 
cycles (e.g. Zuccato et al., 2010; van Nuijs et al., 2011; Ort et al., 2014; Lai et al., 2015), a 67 
potential issue with pure random sampling is that it may not be representative at this more 68 
detailed level, especially as weekly cycles may vary across drug types and regions. For example, 69 
one could imagine a possible scenario where 10 samples would be randomly taken such that the 70 
first five random samples taken would be all from the minimum (trough) days of the weekly 71 
cycle and the next five would be from the maximum (peak) days; then, data analysis would show 72 
a misleading increase after the first five samples due entirely to such unlucky random sampling 73 
practice. By informing a monitoring scheme with details of the weekly cycle characteristics of a 74 
particular given catchment, representative sampling has the potential to avoid this issue.  75 
Page 4 of 32
ACS Paragon Plus Environment
Environmental Science & Technology
 5
The overall objective of the current study is to explore how to design monitoring schemes to 76 
provide cost-effective strategies that allow reliable interpretations of temporal trends. To do this 77 
we measure the performance of different monitoring schemes on a time-series dataset that was 78 
collected through a continuous sampling program over 13 months to monitor the use of cocaine 79 
(COC), methamphetamine (METH), (3,4-methylenedioxymethamphetamine (MDMA) and 80 
methadone (MDONE). Specifically, we aim to (a) demonstrate how knowledge of the weekly 81 
drug-usage cycle can inform efficient sampling schedules, (b) assess how well the trend of drug 82 
use across a year can be estimated when sampling frequency is reduced, and (c) evaluate which 83 
of these truncated monitoring schemes provide adequate results, in a cost-effective manner, 84 
depending on the research goal.  85 
2 Experimental Methods 86 
2.1 Sample collection 87 
The sampling campaign was conducted between 3rd May 2011 and 5th June 2012 (n=346 88 
possible sampling days) at a wastewater treatment plant (WWTP) serving a major urban 89 
catchment of approximately 230,000 people in Southeast Queensland, Australia. A continuous-90 
flow proportional sampling technique was set up at the inlet of the WWTP to ensure the 91 
collection of representative raw wastewater samples (Lai et al., 2015) and daily 24h-composite 92 
samples (6AM–6AM). Samples were collected at 4 °C. Samples were acidified to pH 2 and then 93 
frozen until analysis. The conditions of sample collection and preservation have been commonly 94 
adopted to stabilise the target drug residues in the samples during storage (Chiaia et al., 2008; 95 
van Nuijs et al., 2012). 96 
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As the majority of the data used in the current analysis was presented in Lai et al. (2015), with 97 
the exception of an extra month of observations in May-June 2012, full details of the analytical 98 
methods, quality assurance, quality control and correction factors for back calculation are 99 
presented in Lai et al. (2015), but are also included in the Supplementary Material. The samples 100 
in the current study are labelled by the day in which the sample was physically collected (the 101 
collection day) rather than the day the sample represents (sampled day). Patterns in drug use 102 
were assessed using the estimated consumed mass load (consumption) of each drug (Lai et al., 103 
2011). 104 
2.2 Statistical analysis & external factors 105 
All analysis was completed using the statistical program R (R Core Team, 2013). One of the 106 
key assumptions attached to time-series decomposition is that the data must have equal variance 107 
across the series.  To meet this assumption, log transformations were completed for all drug 108 
consumption levels. As the informed monitoring schemes proposed are based on the known 109 
structure in the data, the weekly cycles in the data needed to be ascertained.  Using the complete, 110 
seven-day data, the log-transformed consumption (to meet normality assumptions) for each drug 111 
was averaged across each of the days of the week. One-way ANOVAs with follow-up Tukey 112 
HSD post-hoc testing, to account for family-wise error rate, were then conducted to ascertain if 113 
the mean drug consumption among days were equal. 114 
There were 58 days in which sampling was not successful and these were encoded as missing 115 
values. There were also a few cases where MDMA fell below detection limit of the analysis 116 
method (15 times, ~4% of MDMA observations). To account for missing values due to left-117 
censoring, random imputation from a Uniform(0, kd) distribution, where kd is the minimum non-118 
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zero value observed for drug d, was completed (see Section 3 in the supplementary material for 119 
further detail). 120 
2.3 Assessing accuracy of monitoring strategies 121 
Due to the weekly cycles observed in the data, a “season” was defined as being a seven-day 122 
period. Time-series analysis was used to decompose the full series, based on loess smoothing 123 
(Cleveland et al., 1990), into a weekly component, an overall trend and a remainder (see Section 124 
6 in the supplementary material for more detail). The “seasonal” component for this data 125 
captures much of the (systematic) weekly variation in the drug  consumption. The overall “trend” 126 
is the long run pattern of drug use, once the seasonal component has been removed. The “error 127 
variance”, or remainder, characterizes any variability that cannot be explained by weekly 128 
variation or overall trend, and as such it holds the information about many of the extreme values 129 
observed over the sampled period.  130 
It is expected that by comparing the trend from the complete data with the trend from a 131 
reduced dataset, we will understand how to undertake reduced sampling whilst retaining the 132 
ability to accurately monitor trends in the data.  133 
The reduced datasets under study comprised twelve candidate monitoring schemes (Table 1), 134 
in which different combinations of days per week were extracted from the complete data set, 135 
using data for MDMA, benzoylecognine (BE, the recommended biomarker for COC in WBE 136 
studies (McCall et al., 2016)), METH and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine 137 
(EDDP, the recommended biomarker for MDONE in WBE studies (McCall et al., 2016)). The 138 
candidate monitoring schemes can be divided into two main sections; those that are informed by 139 
the weekly cycles in the data and those that are not. For the informed monitoring schemes, 140 
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information about the peak, mid and trough sections of the weekly drug use cycle was used to 141 
inform sampling in single or multiple day sets. Schemes which collected samples on weekdays 142 
were preferentially explored to minimize the costs associated with sampling as these days are 143 
typically used in routine wastewater treatment compliance analyses.  These were compared to 144 
results from schemes that did not use the weekly cycles of the data to inform sampling but, 145 
instead, used random or stratified random sampling to measure patterns in drug use. 146 
For both the complete data and each of the reduced samples, the weekly and error variance 147 
components of the time series were extracted and discarded, leaving only the trend in drug use. 148 
Comparisons were made between the trend from the complete sample, which was used as the 149 
benchmark of accuracy, and the trends from the time series with reduced sampling.  As there 150 
were fewer days in the reduced monitoring schemes than in the complete data set, linear 151 
interpolation between estimated trend points for the reduced time series was used (see Section 4 152 
in the supplementary material for details). Interpolation over missing points enabled a Residual 153 
Sums of Squares (RSS) value between the complete and reduced trends to be obtained. The RSS 154 
were used as estimates of goodness of fit between trends - lower RSS values indicated better 155 
accuracy of the reduced time series. The distribution of daily residual values for each scheme 156 
(within each drug) were compared using a standard t-test to ascertain whether the differences 157 
observed were statistically significant (for details, see the supplementary material). To further 158 
quantify the goodness of fit, an R2 value that summarised the scaled difference between the total 159 
variability in the data (total sums of squares) and the RSS was also calculated. In this way, the R2 160 
explains the proportion of variability in the trend of the full data that can be explained by the 161 
trend using the reduced data.  162 
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The RSS is a measure which combines both information about the variance (associated 163 
uncertainty) and bias (consistent over- or under-estimation of the trend) associated with a fitted 164 
model. The RSS alone, therefore, cannot uniquely provide information about inherent bias or 165 
provide information about how well the troughs and peaks of the series can be estimated. To 166 
ascertain these, the complete and restricted data were first collapsed into calendar month chunks. 167 
By using calendar months we guarantee a larger, more consistent sample size from which to 168 
estimate performance. Next, the linear relationship between the complete and restricted data for 169 
each of the monthly mean, minimum and maximum consumption levels were ascertained for 170 
each drug and each sampling scheme (see Section 7 in the supplementary material for more 171 
detail).  The R2 from these fits gives a measure of predictive accuracy, while the slope of the line 172 
provides information about whether the reduced data is consistently under- (slope<1) or over-173 
estimating (slope>1) the features of the complete data (a perfect relationship would have a slope 174 
= 1 and R2 = 1). 175 
To ascertain whether randomly selected weekday sampling strategies were a viable monitoring 176 
strategy, 1000 data sets were created by randomly selecting two weekdays per week from the 177 
complete data set. The resulting 1000 time series were decomposed and a RSS for the difference 178 
between the complete time series trend and each of the 1000 random trends were obtained. In 179 
addition, Ort et al. (2014) proposed two random sampling schemes in which either 56 or 14 180 
samples are collected each year. For these schemes either 10 weekdays (MTWTF) and 4 181 
weekend days (SS) are randomly selected every quarter from across a 365-day period (56 182 
samples), or 10 weekdays and 4 weekend days are randomly selected per year (14 samples). 183 
Following the same analysis approach as above, 1000 data sets were created by randomly 184 
sampling using these strategic rules and the RSS obtained.  The distributions of the 1000 RSS 185 
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values for each of these strategies were compared. It should be noted that, unlike the random 186 
schemes which provide many possible ways to sample the data, the structured sampling schemes 187 
can only be sampled once (as there only exists one observation per day and the schemes sample 188 
the same days every week).  189 
3 Results 190 
3.1 Weekly patterns  191 
One-way ANOVA comparisons showed the consumption of drug for each of the seven days of 192 
the week were different for MDMA (F(6, 339) = 33.48, p ≤ .001), METH (F(6, 339) = 13.54, p ≤ 193 
.001) and COC (F(6, 339) = 87.84, p ≤ .001) and MDONE (F(6, 339) = 2.78, p = .012). Follow-194 
up Tukey HSD post-hoc testing (presented in Tables S1-S3 of the Supplementary Information) 195 
was used to ascertain the groups of days for each drug that would represent peak, trough and mid 196 
consumption levels for each drug (Figure 1). Figure 1 shows that MDMA and COC had the 197 
strongest weekly cycle while METH was less variable throughout the week. A lack of weekly 198 
cycle in MDONE use is also visible in Figure 1 with follow-up testing revealing only one 199 
difference, with samples collected on Tuesdays revealing significantly higher consumption than 200 
those collected on Sundays (p = .020, 95% CI [0.02, 0.33]). 201 
3.2 Uncertainty due to sample size and sampling strategy 202 
The twelve weekly monitoring strategies (Table 1) were applied to the data of all four drugs 203 
and the results in Tables S4 and S5 (supplementary material) include the RSS for the comparison 204 
between the trend in drug use assessed using the complete data and the trend assessed using each 205 
of the twelve monitoring schemes along with their associated R2 values. Tables S4 and S5 206 
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(supplementary material) also show the R2 and slope estimates for the linear relationship for the 207 
monthly means, minimums and maximums between the complete and restricted data.  208 
The monitoring strategies can be broken into three distinct categories; informed single day, 209 
informed multiple day and uninformed monitoring schemes. Informed schemes use the known 210 
weekly structure in the data to inform a sampling scheme that utilises the features of that 211 
structure. Uninformed schemes essentially ignore weekly structure, basing sampling instead on 212 
targeted days of the week or using random (or stratified random) sampling techniques. 213 
Informed Single day monitoring schemes 214 
Figure 2 displays a good example of why using the RSS in combination with measures of the 215 
predictive accuracy associated with estimating the features of the complete data are important.  216 
In Figure 2 the fit of the trend for the one rotating day per week (1RD-52) scheme to the BE data 217 
is displayed in black with the trend from the complete data (both log transformed) in gray behind 218 
it.  Based on the RSS = 9.1, the 1RD-52 scheme seems to be a very good fit (i.e. small magnitude 219 
difference between the full and restricted datasets), but R2 values show a lack of accuracy in the 220 
predictions of monthly mean and minimum  consumption. Therefore, the results in Figure 2 may 221 
provide a reasonable indicator of the overall trend in use, but it cannot accurately represent these 222 
basic components of the data. 223 
The results for the comparison of the four, single day, informed monitoring schemes (peak 224 
only (P-52), mid only (M-52), trough only (T-52), 1RD-52) to the complete data are presented in 225 
Table S4 (supplementary material).  Across all four drugs, the 1RD-52 scheme had the lowest or 226 
equal lowest RSS (Tables S6 to S9), suggesting it was consistently the best single day scheme at 227 
representing the overall trend in drug consumption observed in the complete data (Table S4). 228 
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However, all four single day monitoring schemes displayed an inability to accurately predict 229 
monthly maximum, mean and minimum consumption. 230 
For METH, COC and MDONE the monthly mean   consumption was underestimated by two 231 
or more of the single day schemes while maximum monthly usage of MDMA, METH and COC 232 
was underestimated. Across all the drugs, while the confidence intervals for the slope of the 233 
minimum monthly usage includes the ideal (slope = 1) for most of the schemes (METH, M-52 is 234 
the exception), more than half of the associated R2 values were less than or equal to 0.5, 235 
suggesting large amounts of variability associated with these estimates (Table S4). 236 
Informed multiple day monitoring schemes 237 
For MDMA, METH and COC, all informed multiple day monitoring schemes (Table S5) 238 
produced more accurate estimates than the informed single day schemes (Table S4). Out of the 239 
informed, multiple day monitoring schemes, the peak, mid and trough (PMT-156) monitoring 240 
scheme gave the best overall prediction (lowest RSS) of the overall trend in drug use for 241 
MDMA, METH and COC. For MDMA, although the monthly mean and minimum consumption 242 
were well approximated by the peak and trough (PT-104), two rotating days per week (2RD-104) 243 
and PMT-156 monitoring schemes, only PMT-156 sampling was also able to approximate the 244 
monthly maximum consumption.  245 
For METH, the 2RD-104 sampling showed less bias in the predictions of monthly minimum 246 
and maximum usage than the PT-104 or PMT-156 monitoring strategies, with confidence 247 
intervals for the slope spanning one (the ideal, i.e. unbiased results) and/or claiming a higher R2 248 
value. However, the 2RD-104 scheme for MDONE was only moderately accurate at predicting 249 
minimums in monthly usage while the PT-104 or PMT-156 sampling appeared to be consistently 250 
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the most accurate schemes. For MDONE, although there was no significant difference between 251 
the RSS for the PT-104  and PMT-156 schemes (Table S9) the PT-104 was more accurate at 252 
predicting monthly mean consumption. Although the PT-104 showed less accuracy in predicting 253 
monthly maximum consumption, the decrease in accuracy was only small suggesting this may be 254 
a viable alternative to PMT-156 for sampling MDONE. 255 
For COC, both the PMT-156 and 2RD-104 monitoring strategies were more accurate than the 256 
PT-104 and 1RD-52 monitoring schemes which both tended to over-predict monthly maximum 257 
consumption. The PMT-156 had a significantly lower RSS than the 2RD-104 (Table S8) but the 258 
2RD-104 still explained 99% of the variability in the consumption trend (Table S5). Also, while 259 
the 2RD-104 showed increased accuracy in predicting monthly maximums, the PMT-156 260 
showed greater accuracy in predicting Minimum consumption , suggesting 2RD-104 sampling as 261 
a possible alternative to PMT-156.   262 
Uninformed monitoring schemes 263 
When considering sampling a working week or just taking samples on the weekends, the SS-264 
104 (weekend only) scheme was either the least accurate or equal least accurate of all of the 265 
tested schemes for all four drugs (Tables S6-S9). Across all drugs and all sampling schemes, 266 
MTWTF-260 sampling was the most accurate at predicting the monthly mean, minimum and 267 
maximum consumption (Table S5). However for MDMA, the drug with the highest weekly 268 
variability, although the PMT-156 sampling returned a significantly higher RSS than MTWTF-269 
260 sampling (Table S6) it still explained 98% of the variability in the trend. In addition, the 270 
slope estimates for the monthly mean, minimum and maximum consumption were almost 271 
identical for the PMT-156 and MTWTF-260 schemes. This would suggest, for MDMA, that the 272 
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MTWTF-260 scheme did not improve greatly on the PMT-156 scheme, despite using over 100 273 
additional sampling days.   274 
For METH, COC and MDONE the slopes and R2 values obtained using both PMT-156 and 275 
2RD-104 sampling were comparable to those obtained using MTWTF-260 sampling (Table S5). 276 
Using the 2RD-104 scheme compared to the MTWTF-260, there was a slight, but significant, 277 
decrease in the ability to predict trend (RSS) for METH (Table S7) and COC (Table S8) and no 278 
difference in RSS between the two for MDONE (Table S9), with the reduced schemes still 279 
explained greater than 99% of the variability in the trend from the full data. For MDONE, there 280 
was also no significant difference between the RSS when using PMT-156  versus the MTWTF-281 
260 (Table S9), suggesting the PMT-156 and 2RD-104 schemes may be viable alternatives to 282 
sampling a full working week for METH, MDONE and COC. 283 
Figure 3 displays the results of 1000 data sets created using each of the three random 284 
monitoring schemes R-104, SR-56 and SR-14 for MDMA, METH, COC and MDONE. Each of 285 
the box plots represents the distribution of RSS values from the overall trends predicted using 286 
random data sets compared to the trend in drug use from the complete data, while the four lines 287 
crossing the box plots represent the RSS values gained using the informed monitoring schemes 288 
PT-104, PMT-156, 1RD-52 and 2RD-104. Due to the decreased strength in weekly cycles, for 289 
METH, COC and MDONE, the range of RSS values produced from the random data sets (Figure 290 
3) were much less than for MDMA. Separate One-Way ANOVAs revealed the differences in 291 
RSS between the monitoring schemes observed in Figure 3 were significant for MDMA (F (2, 292 
2997) = 1082, p ≤ .001), METH (F (2, 2997) = 484.3, p ≤ .001), COC (F (2, 2997) = 487.6, p ≤ 293 
.001), and MDONE (F (2, 2997) = 176.9, p ≤ .001). Follow-up Tukey HSD post hoc testing (see 294 
Table S10 in the supplementary material for results) revealed that for MDMA, METH and COC, 295 
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the R-104 had significantly lower average RSS than SR-56. For all four drugs, the R-104 had 296 
significantly lower average RSS than the SR-14 and, in line with the results presented by Ort et 297 
al. (2014), significantly lower average RSS for the SR-56 scheme than for the SR-14. The lack of 298 
difference between the R-104 and SR-56 schemes for MDONE may suggest that for drugs with 299 
no weekly cycle, sampling using the SR-56 may be sufficient if choosing a random monitoring 300 
scheme. Figure 3 does suggest, however, that the R-104 gave more consistent results, due to the 301 
long tail observed in the SR-56 distribution. 302 
The informed monitoring scheme lines for MDONE in Figure 3 highlight that the RSS values 303 
observed are low. Even the worst informed monitoring scheme (1RD-52) had an RSS of 3.2 304 
(Table S4) suggesting that although the 2RD-104 and PMT-156 schemes were both lower than 305 
more than half of the randomly generated data in R-104 and SR-56, the differences may be too 306 
small to be meaningful. Figure 3 shows that for MDMA and METH, however, the PMT-156 307 
scheme had an RSS better than any randomly sampled data set and, for COC, the RSS for PMT-308 
156 was better than any of the SR-56 or SR-14 samples. In addition, for MDMA, METH and 309 
COC, the 2RD-104 RSS values were better than more than half of the R-104 samples which, 310 
given the 2RD-104 scheme has the same number of samples as the R-104 scheme, suggests 311 
making use of the known structure in weekly drug use improves accuracy. 312 
3.3 Discussion 313 
The results, presented in Table 2, suggest options associated with three types of drug use: 314 
1. Measuring a drug with strong weekly cycles (such as MDMA and COC in the current 315 
study) requires sampling across the peak, trough and mid regions of the weekly cycle 316 
every week (156 samples annually) to obtain 98% accuracy (R2=0.98) in estimation of 317 
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the overall trend in drug use along with greater than 90% accuracy (R2=0.90) in 318 
estimating monthly maximum, mean and minimum drug consumption. A two-day-per-319 
week rotating roster that rotates through the three regions could also be implemented 320 
(104 samples), but some loss of accuracy will be experienced. 321 
2. Measuring a drug with weak weekly cycles (such as METH in the current study) still 322 
benefits from sampling across the peak, trough and mid regions of the weekly cycle, 323 
but can be reduced to a two-day-per-week rotating roster that rotates through the three 324 
regions (104 samples). This has accuracy similar to sampling three days per week with 325 
99% accuracy (R2=0.99) in overall trend estimation and 70% or greater accuracy 326 
(R2≥0.70) in estimating the monthly maximum, mean and minimum drug consumption. 327 
3. Measuring a drug with no weekly cycle (such as MDONE in the current study) can be 328 
accurately measured by a two-day-per-week rotating roster (104 samples) with greater 329 
than 99% accuracy (R2>0.99) in estimating the overall trend and 70% or greater 330 
accuracy (R2≥0.70) in estimating monthly maximum, mean and minimum drug 331 
consumption. Reducing to a one-day-per-week rotating roster (52 samples) maintains 332 
overall trend estimation accuracy, estimation of the monthly maximum, mean and 333 
minimums reduces to 50% or greater accuracy (R2≥0.50). Using a random two-day-334 
per-week sample (104 samples) may also provide fair results, as may using the Ort et 335 
al. (2014) SR-56 scheme (56 samples). 336 
For the schemes that were not informed by the weekly structure in drug use, the random and 337 
stratified random schemes investigated did not produce consistently accurate estimates when the 338 
weekly variability in drug use was present. In addition, the uninformed scheme of MTWTF-260, 339 
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although quite accurate, had a high number of sampling days and therefore, a high cost 340 
associated with its implementation (approximately $52,500 AUD annually for the sampling 341 
alone in this study. See Section 10 in the supplementary material for details). For drugs with 342 
strong or moderate weekly cycles, using a monitoring strategy that is informed by the weekly 343 
cycles in the data gave results similar in accuracy to the MTWTF-260 scheme, but with a 344 
fraction of the sampling days. For the current study, compared to the MTWTF-260, the PMT-345 
156 resulted in a 40% decrease in costs while the two day schemes were 60% and the single day 346 
schemes 80% less expensive to run (Supplementary material Section 10).  347 
Although uninformed monitoring schemes provided some accuracy for drugs without an 348 
observable weekly cycle, it should be noted that if the collected samples are to be analysed for 349 
multiple drugs, the monitoring strategy will need to be optimized to measure either the most 350 
highly variable or the most critical. The key then is understanding the weekly cycles of the drugs 351 
being sampled, in the catchment in which the samples are being collected, before sampling 352 
commences.  If information about the weekly cycles of the drugs of interest is not quantitatively 353 
known, then it may be cost-effective to conduct a brief period of intensive sampling to ascertain 354 
the patterns of usage specific to the drug and area being sampled. Exploratory analysis of 1000 355 
random samples from the current data showed that for drugs with a strong weekly cycle of 356 
consumption (such as MDMA or COC), eight weeks of intensive sampling, on average, 357 
identified around 70% of the daily differences observed in the full data (see Section 9 in the 358 
supplementary material for a full discussion). In addition, 95% or more of the samples returned 359 
at least one significant difference between the days.  360 
There are two main problems, however, associated with the use of the reduced, informed 361 
monitoring schemes suggested. The first was highlighted by the results for the 2RD-104 scheme, 362 
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where rare events dramatically reduced the accuracy of the 2RD-104 results. The problem is that, 363 
if a rare event occurs or if a given period of time displays some extreme behaviour that does not 364 
correspond to the regular weekly cycles, there is no guarantee that it will be captured by any 365 
reduced monitoring scheme.  Random sampling ensures that every day is equally likely to be 366 
sampled, increasing the likelihood of sampling rare events that may be missed by informed 367 
monitoring schemes, but even then there is no guarantee that they will be sampled. If sampling 368 
rare events is important to the research question, pre-empting when rare events may occur (such 369 
as music festivals and holidays) and including extra sampling days around that time may provide 370 
some solution.  371 
Rare events are not the only potential problem that using an informed monitoring scheme may 372 
encounter. All of the informed schemes are based on the weekly cycles observed in the data so a 373 
change in the weekly cycle of drug use in the population would not necessarily be captured by 374 
the informed schemes. The problem associated with missing a change in weekly cycle is also 375 
more likely to be avoided using random monitoring schemes for the same reason. The random 376 
monitoring schemes described in Section 2.3, were therefore also considered as a possible way of 377 
accounting for rare events and changes in weekly cycles. However, even though random 378 
sampling may go some way toward measuring rare events and changes in cycle, the results from 379 
the stratified random monitoring schemes highlighted an important problem with random 380 
(stratified or otherwise) sampling in this study:  it is not necessarily representative. When 381 
sampling waste water there is only one chance to sample any given day so, if randomly 382 
sampling, we are equally likely to have sampled data producing any one of the R-104, SR-56 and 383 
SR-14 RSS values observed in Figure 3. Any random sample is equally likely to have drawn 384 
samples from all of the peak usage days, as it is from all of the trough usage days and yet both of 385 
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these samples may tell a wildly different story. This is particularly important for highly variable 386 
drugs, such as MDMA in the current study, in which the days sampled, irrespective of rare 387 
events, can have a large impact on the estimated trends. In this way, by choosing to randomly 388 
sample there is no guarantee that observed trends in drug use are due to fluctuations in the data, 389 
or whether they are just a product of the days sampled. 390 
Although the sorts of informed monitoring schemes presented here have a greater guarantee of 391 
accuracy than the stratified random sampling, they still do not take into account any future 392 
changes in the weekly patterns of drug use that may occur. Because of this, to confirm whether 393 
changes in weekly patterns of usage have occurred, it is also advisable to consider periods of 394 
intensive sampling throughout the monitoring period (especially if monitoring is planned over 395 
many years). 396 
In conclusion, if the aim of monitoring is to determine trends in drug use over time in a given 397 
catchment area, a period of intensive sampling to define weekly cycles in drug use should be 398 
conducted. This should be followed by sampling the peak, trough and middle of the weekly cycle 399 
either three days per week (for drugs with strong weekly patterns of usage), or on a two-day-per-400 
week rotating roster. If monitoring is planned to continue over a long period of time, additional 401 
intensive sampling at intervals throughout the monitoring period are advisable to ascertain if 402 
there have been any changes in the weekly cycle of usage. 403 
FIGURES  404 
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 406 
Figure 1. Days of the week against consumption for MDMA, METH, COC and MDONE. The 407 
days are color coded into peak (white), trough (dark gray) and mid (light gray) consumption 408 
days, based on the results of the ANOVA described in Section 3.1. Clear weekly cycles are 409 
observable for MDMA, COC and METH with peaks in consumption observable around the 410 
collection day Monday and troughs around Thursday and Friday collection points. No weekly 411 
cycle was observable for MDONE. Note that each of the presented box plots here are on 412 
different scales due to the different consumption magnitudes observed for each drug and to allow 413 
observation of the details of the plot. For the same reason, MDMA, COC and METH plots have 414 
been zoomed in, resulting in some outlying values resting outside of the plot area. 415 
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 417 
Figure 2. The results for using one rotating day per week (1RD-52) to estimates overall trend, 418 
and monthly maximum, minimum and mean log(cocaine) consumption. The upper left figure 419 
displays the trend from the time series decompositions (with seasonal and error components 420 
removed) of the complete data (gray) in comparison to the 1RD-52 reduced data (black). The 421 
remaining three panels display the relationship between the monthly estimates of maximum, 422 
minimum and mean log(consumption) for the complete and reduced data sets. Although the 423 
overall trend in consumption appears to be well estimated, consistent underestimation of the 424 
monthly consumption is evident across all measures suggesting RSS alone is not sufficient for 425 
estimating the accuracy of the sampling schemes. 426 
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 428 
Figure 3. The distribution of RSS values (y-axis) for the comparison between the overall trend in 429 
consumption for the full data and the overall trend in consumption for data obtained using the 430 
three random sampling schemes; R-104, SR-56 and SR-14 (x-axis) for each of the four drugs. 431 
Each box-and-whisker represents the distribution of RSS values generated by comparing the full 432 
trend from the decomposed time series of 1000 data sets which were created by randomly 433 
selecting days from the complete data set (as described in Section 2.3). The RSS from the PT, 434 
PMT, 1RD and 2RD structured schemes are overlaid, with the value of the highest RSS indicated 435 
on the y-axis for ease of comparison (Tables S4 & S5). Note that each of the presented box plots 436 
here are on different scales due to the different RSS magnitudes observed for each drug and to 437 
allow observation of the details of the plot. For the same reason, each plot has been zoomed in, 438 
resulting in some outlying values resting outside of the plot area.   439 
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TABLES.  440 
Table 1. Monitoring schemes investigated in the current study.  441 
Monitoring Scheme Description # of 
Samples 
Informed  P-52 Peak usage (Monday) only 52 
M-52 Mid usage (Wednesday)  only 52 
T-52 Trough usage (Friday) only 52 
1RD-52 One day per week is sampled, but the day chosen rotates through peak, mid 
and trough usage. For example, in week 1 - Peak is sampled, week 2 - Mid 
is sampled, week 3 - Trough is sampled and this pattern is repeated 
52 
PT-104 The peak and trough (Monday and Friday) 104 
2RD-104 Two days per week are sampled, but the days chosen rotate through peak, 
mid and trough usage. For example, in week 1 – Peak and Mid are sampled, 
week 2 – Mid and Trough are sampled, week 3 – Peak and Trough are 
sampled and this pattern is repeated 
104 
PMT-156 The peak, mid and trough usage (Mondays, Wednesdays and Fridays) 156 
Uninformed SR-14 Proposed by Ort et al. (2014), this scheme randomly selects 10 weekdays 
(MTWTF) and four weekend days (SS) from across a 365 day period 
14 
SR-56 Proposed by Ort et al. (2014), this scheme randomly selects 10 weekdays 
(MTWTF) and four weekend days (SS) every quarter from across a 365 day 
period 
56 
R-104 Sampling occurs on two randomly chosen weekdays (MTWTF) every week  104 
SS-104 Both weekend days (Saturday and Sunday) 104 
MTWTF-
260 
Every weekday (excluding weekends) 260 
The details of the 12 monitoring schemes investigated in the current manuscript. They span 14-442 
260 sampling days per year and include schemes informed by the weekly cycles in the data and 443 
those that are independent of those cycles. Here the “day” is defined as the day the sample was 444 
physically collected (collection day).  445 
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Table 2. Ranking of Sampling Scheme Results for the informed sampling schemes along with 446 
the MTWTF-260 and SS-104 across all four drugs.  447 
MDMA 
Strong weekly cycle 
METH 
Weak weekly cycle 
COC 
Strong weekly cycle 
MDONE 
No weekly cycle 
Scheme Detail Scheme Detail Scheme Detail Scheme Detail 
MTWTF-
260 
Accurate across all 
measures. 
MTWTF-
260 
Moderate predictive 
ability of monthly 
minimums. 
MTWTF-
260 
Accurate across all 
measures. 
MTWTF-
260 
Moderate 
predictive ability 
for monthly 
minimums. 
PMT-156 PMT-156 
Slight decrease in 
ability to predict 
trend in usage. 
Moderate predictive 
ability of monthly 
minimums and 
maximums. 
PMT-156 Decrease in ability 
to predict trend in 
usage. Moderate 
predictive ability of 
monthly means and 
minimums. 
PMT-156 
Moderate 
predictive ability 
of monthly 
means, 
minimums and 
maximums. 
2RD-104  
Decrease in ability to 
predict trend in 
usage. Moderate 
predictive ability of 
monthly maximums. 
2RD-104 2RD-104 2RD-104 
PT-104 PT-104 
Decrease in ability to 
predict trend in 
usage. Moderate 
predictive ability of 
monthly minimums 
and maximums. 
PT-104 
Decrease in ability 
to predict trend in 
usage. Moderate 
predictive ability of 
monthly means. 
Poor predictive 
ability of monthly 
minimums. 
PT-104 
1RD-52  
Decrease in ability to 
predict trend in 
usage. Weak 
predictive ability of 
monthly maximums. 
Moderate predictive 
ability of monthly 
minimums and 
means. 
1RD-52 1RD-52 
Decrease in ability 
to predict trend in 
usage. Moderate 
predictive ability of 
monthly means and 
maximums. Poor 
predictive ability of 
monthly minimums. 
1RD-52 
M-52 SS-104 SS-104 
Although M-52 had 
less predictive 
ability of the trend 
in usage than SS-
104 and had poor 
predictive ability of 
monthly 
maximums, SS-104 
showed a complete 
inability to predict 
monthly minimums.  
Moderate predictive 
ability of monthly 
means. 
T-52 
SS-104  
Decrease in ability to 
predict trend in 
usage. Unable to 
predict monthly 
maximums. 
Moderate predictive 
ability of monthly 
minimums. 
M-52 
Decrease in ability to 
predict trend in 
usage. Weak 
predictive ability of 
monthly minimums 
and maximums.  
Moderate predictive 
ability of monthly 
mean usage. 
M-52 M-52 
Poor predictive 
ability of monthly 
minimums and 
maximums. SS-
104 had a 
decrease in ability 
to predict trend in 
usage but showed 
moderate 
predictive ability 
of monthly 
means, while P-
52 and M-52 
showed poor 
predictive ability 
of monthly 
means. 
T-52 
Decrease in ability to 
predict trend in 
usage. Consistently 
under-predicts or 
over-Predicts 
respectively. 
T-52 
Decrease in ability to 
predict trend in 
usage. Consistently 
under-predicts or 
over-Predicts 
respectively. 
T-52 
Decrease in ability 
to predict trend in 
usage. Consistently 
under-predicts or 
over-Predicts 
respectively. 
P-52 
P-52 P-52 P-52 SS-104 
The MTWTF-260 was the most accurate performer for all drugs with the PMT-156 and 2RD-448 
104 also performing well. The P-, M- and T-52, along with the SS-104 were the least accurate at 449 
predicting overall trend in consumption and monthly mean, maximum and minimum 450 
consumption across all four drugs. It should be noted that the R-104, SR-56 and SR-14 do not 451 
Page 24 of 32
ACS Paragon Plus Environment
Environmental Science & Technology
 25
provide enough information to gain estimates of monthly mean, maximum and minimum 452 
consumption and are therefore not included in this table.  453 
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